Dr. Biao Lu's lab focuses on developing innovative nanomedicines to combat Alzheimer's disease through targeted removal of toxic proteins. They utilize exosomes, which are tiny vesicles that cells use for communication, to specifically target and break down amyloid-beta proteins that are known to accumulate in the brains of Alzheimer's patients. The research aims to improve current treatment options and offers potential solutions for other amyloid-related disorders.